Use of Atypical Antipsychotics in the Treatment of Autistic Disorder

@article{Stachnik2007UseOA,
  title={Use of Atypical Antipsychotics in the Treatment of Autistic Disorder},
  author={Joan M. Stachnik and Cheryl L Nunn-Thompson},
  journal={Annals of Pharmacotherapy},
  year={2007},
  volume={41},
  pages={626 - 634}
}
Objective: To review clinical trials and reports describing the efficacy and safety of atypical antipsychotics (olanzapine, ziprasidone, quetiapine, aripiprazole) in the treatment of autistic or other pervasive developmental disorders. Data Sources: English-language publications from the MEDLINE database (1966–February 2007) including clinical trials, case reports, and retrospective series were reviewed. Study Selection and Data Extraction: Relevant data were extracted from studies of selected… Expand
Aripiprazole in patients with autistic spectrum disorders: a review and case reports
Background: Although a significant amount of literature regarding use of aripiprazole (APZ) in autistic spectrum disorders (ASDs) has benne published, APZ is not approved for use in autism or ASDs inExpand
Atypical and Typical Antipsychotics in the Schools.
The use of antipsychotic medications within the school-age population is rapidly increasing. Although typical antipsychotics may be used in rare cases, this influx is largely secondary to theExpand
Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis.
  • Akanksha Sharma, S. Shaw
  • Psychology, Medicine
  • Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
  • 2012
TLDR
Outcome measures demonstrated mean improvement in problematic behaviors equaling one standard deviation, and thus current evidence supports the effectiveness of risperidone in managing behavioral problems and symptoms for children with ASD. Expand
Pharmacological Treatment of Autism
TLDR
Evidence from controlled studies indicates that the atypical antipsychotic drug risperidone is frequently effective for ameliorating symptoms of irritability, hyperactivity, social withdrawal, and stereotypic, repetitive behavior. Expand
Quetiapine abuse and dependence in psychiatric patients: a systematic review of 25 case reports in the literature
Abstract Background: Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder and major depressive disorder. There has been a growing amount of quetiapineExpand
Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Irritability in Autistic Children
  • E. Kirino
  • Medicine
  • Clinical medicine insights. Pediatrics
  • 2014
TLDR
Head-to-head comparison studies are needed to support that aripiprazole may be a promising drug that can be used to treat irritability in autistic children, and risperidone has the greatest amount of evidence supporting it, including randomized controlled trials; thus, its efficacy and tolerance has been established in comparison with other agents. Expand
Control of psychomotor agitation and aggressive behavior in patients with autistic disorder: a retrospective chart review.
TLDR
Second-generation antipsychotics seem to reduce psychomotor agitation and aggressive behavior in patients with autistic spectrum disorder; however, further studies are required to evaluate the side effects of these drugs in relation to their beneficial effects. Expand
Antipsychotics for Children and Young Adults: A Comparative Effectiveness Review
TLDR
This is the first comprehensive review comparing the effectiveness and safety across the range of antipsychotics for children and young adults and found some SGAs have a better side effect profile than other SGAs. Expand
Buspirone for Autistic Disorder in a Woman with an Intellectual Disability
TLDR
The reduction in target aggressive behaviors achieved with buspirone therapy allowed other treatment interventions to proceed more effectively in the patient, and Clinicians may wish to consider use of busPirone in patients with AD who do not respond to or have risk factors (or use of other therapy). Expand
Treating pediatric patients with antipsychotic drugs: balancing benefits and safety.
TLDR
This article reviews the current trends for the therapeutic use of antipsychotic medications in pediatric psychiatry and the available data that support their efficacy, but it also discusses important issues related to their safety during both short-term and long-term administration. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 70 REFERENCES
Second-generation antipsychotic medications in children and adolescents.
TLDR
Evidence suggests that second-generation antipsychotics are efficacious in the treatment of psychosis, bipolar disorders, pervasive developmental disorders, and Tourette's Disorder, and are potentially useful in mental retardation, conduct disorder, and severe attention deficit hyperactivity disorder. Expand
Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.
TLDR
The findings suggest that olanzapine is a promising treatment for children with autistic disorder and further placebo-controlled and long-term studies of olanZapine in autistic disorder are required. Expand
Open-Label Study of Olanzapine in Children with Pervasive Developmental Disorder
TLDR
Olanzapine was a relatively safe medication in children, its clinical relevance in children with pervasive developmental disorder may be limited, and three children showed extrapyramidal symptoms that disappeared after the dose was lowered. Expand
Olanzapine in the treatment of pervasive developmental disorders: a case series analysis.
TLDR
All patients showed clinically significant improvement on the Clinical Global Impressions scale, as well as an improved score as measured by the Global Assessment of Functioning scale, which support the use of long-term olanzapine therapy for symptom control in patients with pervasive developmental disorders. Expand
Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series
TLDR
Aripiprazole was well tolerated and effective in each of the cases and appears to be a safe and efficacious alternative in the management of patients with both intellectual disabilities and schizophrenia. Expand
Treating Functional Impairment of Autism with Selective Serotonin-Reuptake Inhibitors
TLDR
Benefits with SSRIs in treating functional impairments in autism have been observed and current evidence does not support selection of one SSRI over another for any impairment associated with autism. Expand
Quetiapine in nine youths with autistic disorder.
TLDR
The data suggest that quetiapine may not be a particularly effective agent in the treatment of adolescent patients with AD, and it seems reasonable that they be conducted with more rigor, less treatment-resistant cohorts, and, possibly, a different dosing strategy. Expand
A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.
TLDR
Quetiapine was modestly effective for maladaptive behavior in patients with a PDD. Expand
The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.
TLDR
In adults with autism, a switch to ziprasidone from other atypical antipsychotics appears to have the potential for maintaining beneficial effect on behavior while improving major health indices including weight and lipid levels. Expand
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.
TLDR
Preliminary results suggest that olanzapine may be an effective and well tolerated drug in targeting core and related symptoms of PDDs in children, adolescents, and adults. Expand
...
1
2
3
4
5
...